OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
69 hedge funds and large institutions have $83.9M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
5% less capital invested
Capital invested by funds: $88.1M → $83.9M (-$4.14M)
Holders
69
Holding in Top 10
1
Calls
$3K
Puts
–
Top Buyers
| 1 | +$17.5M | |
| 2 | +$6.49M | |
| 3 | +$1.33M | |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
+$753K |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$570K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$2.33M | |
| 3 | -$820K | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$205K |
| 5 |
PP
PDT Partners
New York
|
-$138K |